Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | NYU6UTW25B |
InChI Key | KPYSYYIEGFHWSV-QMMMGPOBSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C10H12ClNO2 |
Molecular Weight | 213.66 |
AlogP | 1.86 |
Hydrogen Bond Acceptor | 2.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 4.0 |
Polar Surface Area | 63.32 |
Molecular species | ZWITTERION |
Aromatic Rings | 1.0 |
Heavy Atoms | 14.0 |
Action | Mechanism of Action | Reference |
---|---|---|
AGONIST | GABA-B receptor agonist | PubMed |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | - | - | - | 12 | |
Membrane receptor
Family C G protein-coupled receptor
Small molecule receptor (family C GPCR)
Neurotransmitter receptor (family C GPCR)
GABA-B receptor
|
1000 | 32-140 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Fragile X Syndrome | 3 | D005600 | ClinicalTrials |
Child Development Disorders, Pervasive | 3 | D002659 | ClinicalTrials |
Muscle Spasticity | 3 | D009128 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 69308-37-8 |
ChEMBL | CHEMBL301742 |
DrugBank | DB08891 |
EPA CompTox | DTXSID90219366 |
FDA SRS | NYU6UTW25B |
Guide to Pharmacology | 3428 |
PDB | 2C0 |
PubChem | 44602 |
SureChEMBL | SCHEMBL351220 |
ZINC | ZINC000000000061 |